Aquestive Therapeutics, Inc. (AQST)

USD 2.52

(2.02%)

Total Assets Summary of Aquestive Therapeutics, Inc.

  • Aquestive Therapeutics, Inc.'s latest annual total assets in 2023 was 57.41 Million USD , up 3.13% from previous year.
  • Aquestive Therapeutics, Inc.'s latest quarterly total assets in 2024 Q2 was 117.6 Million USD , down -9.2% from previous quarter.
  • Aquestive Therapeutics, Inc. reported annual total assets of 55.67 Million USD in 2022, down -10.19% from previous year.
  • Aquestive Therapeutics, Inc. reported annual total assets of 61.99 Million USD in 2021, down -1.42% from previous year.
  • Aquestive Therapeutics, Inc. reported quarterly total assets of 117.6 Million USD for 2024 Q2, down -9.2% from previous quarter.
  • Aquestive Therapeutics, Inc. reported quarterly total assets of 109.95 Million USD for 2024 Q3, down -6.5% from previous quarter.

Annual Total Assets Chart of Aquestive Therapeutics, Inc. (2023 - 2016)

Historical Annual Total Assets of Aquestive Therapeutics, Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 57.41 Million USD 3.13%
2022 55.67 Million USD -10.19%
2021 61.99 Million USD -1.42%
2020 62.88 Million USD -19.87%
2019 78.47 Million USD -9.64%
2018 86.85 Million USD 101.44%
2017 43.11 Million USD 9.46%
2016 39.38 Million USD 0.0%

Peer Total Assets Comparison of Aquestive Therapeutics, Inc.

Name Total Assets Total Assets Difference
Collegium Pharmaceutical, Inc. 1.14 Billion USD 94.978%
Embecta Corp. 1.21 Billion USD 95.272%
ANI Pharmaceuticals, Inc. 904.42 Million USD 93.651%
Dynavax Technologies Corporation 997.09 Million USD 94.241%
Esperion Therapeutics, Inc. 205.79 Million USD 72.1%
Pacira BioSciences, Inc. 1.57 Billion USD 96.353%
PainReform Ltd. 9.93 Million USD -478.228%
Sunshine Biopharma, Inc. 27.34 Million USD -109.961%
SCYNEXIS, Inc. 128.41 Million USD 55.286%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -148.272%
Cosmos Health Inc. 66.29 Million USD 13.391%
Journey Medical Corporation 76.84 Million USD 25.285%
Sunshine Biopharma, Inc. 27.34 Million USD -109.961%
Safety Shot Inc 12.7 Million USD -351.784%
Alpha Teknova, Inc. 128.58 Million USD 55.347%
Intra-Cellular Therapies, Inc. 728.29 Million USD 92.116%
Bright Green Corporation 17.4 Million USD -229.931%
Procaps Group, S.A. 460.18 Million USD 87.523%
Theratechnologies Inc. 77.76 Million USD 26.169%
Harrow Health, Inc. 311.75 Million USD 81.582%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -285.537%
Biofrontera Inc. 27.93 Million USD -105.564%
DURECT Corporation 45.18 Million USD -27.062%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 95.925%
Cronos Group Inc. 1.13 Billion USD 94.938%
OptiNose, Inc. 107.72 Million USD 46.701%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 87.811%
Kala Pharmaceuticals, Inc. 55.94 Million USD -2.626%
RedHill Biopharma Ltd. 23.04 Million USD -149.133%
Organogenesis Holdings Inc. 460.02 Million USD 87.519%
Guardion Health Sciences, Inc. 11.91 Million USD -381.768%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 29.786%
Radius Health, Inc. 1.71 Billion USD 96.654%
Universe Pharmaceuticals INC 53.28 Million USD -7.752%
ProPhase Labs, Inc. 91.92 Million USD 37.54%
Phibro Animal Health Corporation 982.18 Million USD 94.154%
Procaps Group S.A. 460.18 Million USD 87.523%
Alvotech 950.09 Million USD 93.957%
TherapeuticsMD, Inc. 43.3 Million USD -32.578%
Viatris Inc. 47.68 Billion USD 99.88%
Rockwell Medical, Inc. 52.17 Million USD -10.053%
Aytu BioPharma, Inc. 118.09 Million USD 51.38%
SIGA Technologies, Inc. 254.83 Million USD 77.469%
Tilray Brands, Inc. 4.33 Billion USD 98.676%
Lifecore Biomedical, Inc. 273.7 Million USD 79.022%
Shineco, Inc. 84.17 Million USD 31.791%
PetIQ, Inc. 868.22 Million USD 93.387%
Regencell Bioscience Holdings Limited 8.43 Million USD -580.452%
Incannex Healthcare Limited 17.04 Million USD -236.822%
Neurocrine Biosciences, Inc. 3.25 Billion USD 98.234%
Alimera Sciences, Inc. 153.52 Million USD 62.6%
Silver Spike Investment Corp. 88.57 Million USD 35.177%
Assertio Holdings, Inc. 286.41 Million USD 79.953%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -864.727%
Petros Pharmaceuticals, Inc. 33.79 Million USD -69.897%
Clever Leaves Holdings Inc. 31.24 Million USD -83.779%
Cyclo Therapeutics, Inc. 13.24 Million USD -333.424%
Avadel Pharmaceuticals plc 261.12 Million USD 78.011%
Hempacco Co., Inc. 18.04 Million USD -218.227%
Talphera, Inc. 20.39 Million USD -181.53%
Alvotech 950.09 Million USD 93.957%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 85.863%
Lantheus Holdings, Inc. 1.65 Billion USD 96.523%
Currenc Group, Inc. 141.49 Million USD 59.419%
Kamada Ltd. 351.96 Million USD 83.687%
Indivior PLC 1.95 Billion USD 97.057%
Evoke Pharma, Inc. 7.06 Million USD -712.303%
Flora Growth Corp. 23.62 Million USD -143.029%
Cyclo Therapeutics, Inc. 13.24 Million USD -333.424%
Evolus, Inc. 188.99 Million USD 69.62%
HUTCHMED (China) Limited 1.27 Billion USD 95.513%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 96.205%
Akanda Corp. 8.83 Million USD -549.525%